ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1805

Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake

Sho Fukui1, Masato Okada2, Tomohiro Shinozaki3, Takahiro Asano2, Takehiro Nakai2, Hiromichi Tamaki2, Mitsumasa Kishimoto4, Hiroshi Hasegawa5, Takeaki Matsuda5, Javier Marrugo1, Sara Tedeschi1 and Daniel Solomon6, 1Brigham and Women's Hospital, Boston, MA, 2St. Luke's International Hospital, Tokyo, Japan, 3Tokyo University of Science, Tokyo, Japan, 4Kyorin University School of Medicine, Yokohoma, Japan, 5Kyorin University, Tokyo, Japan, 6Brigham and Women's Hospital, Newton, MA

Meeting: ACR Convergence 2023

Keywords: Epidemiology, Uric Acid, Urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1796–1826) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Cross-sectional epidemiologic studies support a direct relationship between alcohol intake and serum urate (SU). These observations are parts of the basis for gout recommendations suggesting limiting alcohol intake. However, it is unknown whether reductions in alcohol intake over time are associated with reductions in SU. Hence, we evaluated the relationship between changes in daily alcohol intake and changes in SU levels.

Methods: This longitudinal observational study used prospectively collected annual medical checkup data at a large medical checkup center in Japan. At each visit, daily alcohol intake information was collected using a standardized collection tool, and SU was routinely measured. We included consecutive participants with at least two visits from Oct 2012 to Oct 2022. Participants who received treatment for hyperuricemia or gout during the study period were excluded. The outcome was a change in SU between two visits, and exposures of interest were changes in total daily alcohol intake and in specific types of alcoholic beverage intake (e.g., beer, whiskey, wine, sake, shochu, and others). We used a linear mixed-effect model with random intercepts to take longitudinal intrapersonal correlations into account. We adjusted for SU and alcohol consumption at a prior visit. In addition, age, sex, body mass index, eGFR, medication use, smoking status, daily activity level, exercise level, and results of dietary questionnaires measured at prior visits were adjusted for in primary analyses. In secondary analyses, covariates measured at subsequent visits were also included. As well, we examined the associations in people who fully discontinued alcohol consumption and in sub-groups.

Results: A total of 63,486 participants with 370,572 visits were included in the analyses. The mean (standard deviation) age was 48.0 (12.9) years, and 28,578 (45.0%) were male. 37,199 (58.6%) were regular alcohol drinkers with a median alcohol intake of 1.4 drink/day. The mean interval between visits was 1.3 years. There were 149,441 episodes of changing daily alcohol intake in 41,661 participants (Table 1). The primary analysis showed a significant but very small association between one alcoholic drink decrease and SU (SU change -0.019 [-0.021, -0.017] mg/dL; p< 0.001); the association varied based on the type of alcohol consumed. The extents of the associations were almost the same in secondary analyses and when we focused on the visits where participants fully discontinued regular alcohol intake (Figure 1). In stratified sub-group analyses, larger but still small changes in SU were observed in younger participants, lighter drinkers, and those with higher initial SU levels. (Figure 2).

Conclusion: Although alcohol intake is associated with acute gout events, this study found that longitudinal changes in daily alcohol consumption did not result in clinically relevant changes in chronic SU levels. Reducing alcohol intake alone is unlikely to be a major driver of reductions in chronic SU in the general population.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: S. Fukui: None; M. Okada: AbbVie/Abbott, 6, Eli Lilly, 6, Pfizer, 6; T. Shinozaki: None; T. Asano: None; T. Nakai: None; H. Tamaki: AbbVie, 6, Astellas Pharma, 6, Ayumi, 6, Chugai pharmaceutical, 6, Kyowa-Kirin, 6, Ono pharmaceutical, 6, Takeda Pharmaceutical, 6, Tanabe-Mitsubishi, 6; M. Kishimoto: AbbVie, 2, 6, Amgen, 2, 6, Asahi-Kasei Pharma, 2, 6, Astellas, 2, 6, Ayumi Pharma, 2, 6, Bristol-Myers Squibb(BMS), 2, 6, Celgene, 2, 6, Chugai, 2, 6, Daiichi-Sankyo, 2, 6, Eisai, 2, 6, Eli Lilly, 2, 6, Gilead, 2, 6, Janssen, 2, 6, Novartis, 2, 6, Ono Pharma, 2, 6, Pfizer, 2, 6, Tanabe-Mitsubishi, 2, 6, UCB, 2, 6; H. Hasegawa: None; T. Matsuda: None; J. Marrugo: None; S. Tedeschi: Novartis, 2; D. Solomon: CorEvitas, 5, Janssen, 5, Moderna, 5, Novartis, 5.

To cite this abstract in AMA style:

Fukui S, Okada M, Shinozaki T, Asano T, Nakai T, Tamaki H, Kishimoto M, Hasegawa H, Matsuda T, Marrugo J, Tedeschi S, Solomon D. Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/longitudinal-changes-in-serum-urate-associate-minimally-with-changes-in-daily-alcohol-intake/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/longitudinal-changes-in-serum-urate-associate-minimally-with-changes-in-daily-alcohol-intake/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology